Depression and diabetes management often overlap in ways that make treatment decisions more complicated. Patients with type 2 diabetes frequently experience depression, and depression can make daily self-care harder. However, some commonly prescribed antidepressants and psychotropic medications may contribute to weight gain, worsen insulin resistance, or complicate long-term metabolic control. …
Read More »Why Oral Health Is Becoming Part of Diabetes Management
A bleeding gumline might seem like a minor dental issue, but researchers are increasingly finding that it can signal much more than a need to floss. Chronic inflammation inside the mouth may influence blood sugar control, cardiovascular health, and even long-term diabetes outcomes. As evidence continues to grow, healthcare providers …
Read More »Why More Diabetes Patients Are Being Referred for Sleep and Circadian Evaluations
Poor sleep does more than leave people tired the next day. For many individuals living with diabetes, disrupted sleep may quietly worsen glucose control, increase cardiovascular risk, and complicate long-term metabolic health. As research continues to uncover the close relationship between sleep and metabolic function, more healthcare providers are referring …
Read More »When A1C Improves but the Patient Doesn’t: Rethinking What “Good Control” Really Means
Improving hemoglobin A1C has long been considered the gold standard in diabetes care. However, many clinicians now question whether lower numbers always translate into healthier, happier patients. The growing debate over how A1C levels relate to real-world diabetes outcomes highlights an important issue in modern medicine: a patient can achieve …
Read More »When GLP-1 Therapy Plateaus: What Clinicians Should Do Next
Everything seems to be working perfectly until it suddenly isn’t. A patient is losing weight steadily, HbA1c levels are improving, and confidence is high during every follow-up visit. Then progress slows. The scale barely changes. Blood sugar readings stop improving. Patients start asking whether the medication has stopped working, while …
Read More »Diabetes Treatment Persistence: Why Patients Stop Therapy and What Clinicians Can Do
Why do so many patients begin treatment with good intentions, only to fall off track later? Staying consistent with diabetes treatment continues to challenge both patients and clinicians despite medical advances. While new therapies offer better control, long-term success still depends on consistency. However, many patients struggle to maintain routines, …
Read More »GLP-1 Resistance in Diabetes Care: Should Poor Response Change Treatment Strategy?
Why do some patients see impressive results with GLP-1 therapies while others barely respond? This question is becoming more relevant as clinicians encounter variability in outcomes. GLP-1 resistance is emerging as a possible explanation for suboptimal responses in certain individuals with diabetes. As a result, understanding how to identify and …
Read More »Postprandial Glucose Spikes: Are We Missing the Most Actionable Metric in Diabetes Care?
When managing diabetes, most people focus on A1C or time in range. However, what if the real opportunity lies in something more immediate and actionable? Managing post-meal blood sugar, often called postprandial glucose control, may hold the key to better outcomes. While long-term markers still matter, post-meal spikes often go …
Read More »GLP-1 Therapy and Diagnostic Drift: Are We Masking Disease Progression?
Disease progression in patients using GLP-1 therapies is becoming a critical topic as these medications continue to reshape diabetes care. While GLP-1 receptor agonists improve glycemic control and support weight loss, could they also be hiding deeper metabolic decline? Much like a polished surface that conceals underlying cracks, improved lab …
Read More »GLP-1 Dose Escalation in 2026: High-Dose Era?
GLP-1 dose escalation is quickly becoming a central topic in diabetes care, especially as higher dosing strategies gain traction. But are we truly entering a high-dose era, or simply refining how we use these powerful agents? As clinicians face patients who plateau on standard regimens, the question becomes not just …
Read More »
Diabetes In Control. A free weekly diabetes newsletter for Medical Professionals. News and information for Medical Professionals.